Recruiting studies
Idiopathic Pulmonary Fibrosis
Study
Study on protecting the tissue in your lungs affected by idiopathic pulmonary fibrosis
About the study commissioned by Diex Recherche:
Idiopathic pulmonary fibrosis is a progressive lung disease that causes tissue in the lungs to scar, making it increasingly difficult to breathe.
Although there is no cure, our study evaluates the possibility of the study drug to slow the progression of the disease and improve quality of life.
By participating in the study, you could possibly see an improvement in your breathing, less coughing and less accumulated fatigue related to the condition.
Why participate?
Contribute to medical research: Your participation can help develop an innovative treatment for idiopathic pulmonary fibrosis.
Access to study-related care: Close monitoring by an experienced medical team and no-cst examinations linked to the study.
Financial reimbursement: Reimbursement is offered for your time and travel, if you meet the eligibility criteria.
Who is eligible?
We invite to participate individuals who:
- Are aged 40 and over
- Have a confirmed diagnosis of idiopathic pulmonary fibrosis within 5 years
How does it work?
Pre-registration: Start by completing our online pre-registration form to help us determine if you may be eligible.
Initial Assessment: If you are considered pre-eligible, an invitation will be sent to you to come to our center for a detailed assessment.
Participation: After confirmation of your eligibility, you will receive all the information required to begin your participation in this study.
I want to apply to this clinical study
For more information, contact us at 819 801-9797 (Trois-Rivières) or at 1-844-739-3439 (toll free), or fill the online form.
The study process in pictures
Explanation
Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.
Meeting
Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.
Decision
Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.
Tests
Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.
Departure
Step 5 | If you are eligible, you may then begin a clinical study with us.
